ISCBH Webinars


A SERIES OF THREE ISCBH WEBINARS FOR 2025
This new series will cover the following topics:
Achondroplasia & Hypochondroplasia
Hypophosphatasia
Osteogenesis Imperfecta
For each of our webinars, we are excited to be addressing some of the issues that we all need answers to – What about the unmet needs of patients? What if there was no limit to funding? Where have we been and where are we going?
We’ll be looking into each topic with a futuristic lens… and welcoming plenty of engagement between our moderators and audience! Together we can work to channel our future efforts to address those unmet needs.
The webinars will last one hour, starting with a 25 minute talk by our guest speaker, followed by a 35 minute Q&A and discussion session chaired by Professor Leanne Ward and Professor Erik Imel.
Webinar Series Convenors:

Erik Imel
Indianapolis, USA

Leanne Ward
Ottowa, Canada
'The Future of...' Webinar #2

THE FUTURE OF…
Hypophosphatasia
14:00-15:00 CST, 15:00-16:00 EST, 20:00-21:00 GMT CHAIRS: Erik Imel & Leanne Ward
Dr Jill Simmons
Dr. Jill Simmons is a Professor of Pediatrics in the Ian M Burr Division of Pediatric Endocrinology and Diabetes at Vanderbilt University Medical Center. She is the founder and director of the Vanderbilt Program for Pediatric Metabolic Bone Disorders, the founder and chair of the Hazinski Society for Faculty Development, and the Director for Faculty Mentorship Programs in the Department of Pediatrics at Vanderbilt University. She is a member of the scientific advisory board for Soft Bones as well as the Rare Bone Disease Alliance.
Dr. Simmons’ clinical and research interests include type 1 diabetes as well as pediatric metabolic bone diseases such as hypophosphatasia, osteogenesis imperfecta, osteopetrosis, hypophosphatemia, osteoporosis, and rickets. She has been a successful local principal investigator for multiple groundbreaking clinical trials in metabolic bone disease, including asfotase alpha in infants with severe hypophosphatasia, romozosumab and setrusumab in pediatric patients with osteogenesis imperfecta, and burosumab in pediatric patients with hypophosphatemic rickets. She is also an active investigator in several international longitudinal observational registries and multiple ongoing clinical trials.
Dr. Simmons has published more than 80 manuscripts in peer reviewed journals, including but not limited to the New England Journal of Medicine, Lancet, Journal of the American Medical Association, Journal of Pediatrics, and Diabetes Care. She serves as a regular reviewer for journals in her field and regularly presents her research at national and international meetings.
In addition to her research, she is an active clinician and educator. She spends the majority of her time with patients as well as educating pediatric residents and endocrinology fellows to better care for children with endocrine diseases. She has won the highest patient experience award at Vanderbilt University Medical Center every year since its inception in 2017.
Previous Webinars
The recording of the Winter Webinar is available for viewing for ISCBH Members and can be found on the Members section of the website.
